RESCON IMP (Rescon extended release 12 mg / 1.25 mg / 40 mg)
Generic Name: chlorpheniramine/methscopolamine/phenylephrine
Pill imprint RESCON IMP has been identified as Rescon extended release 12 mg / 1.25 mg / 40 mg.
Rescon Extended Release is used in the treatment of nasal congestion; rhinitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Rescon Extended Release 12 mg / 1.25 mg / 40 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- chlorpheniramine/methscopolamine/phenylephrine
- Imprint:
- RESCON IMP
- Strength:
- 12 mg / 1.25 mg / 40 mg
- Color:
- Purple / Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Capellon Pharmaceuticals
- National Drug Code (NDC):
- 64543-0096
More about Rescon Extended Release (chlorpheniramine / methscopolamine / phenylephrine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- 0 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Consumer resources
Other brands: AH-Chew, AlleRx Dose Pack PE (PM Dose), Extendryl Chews, Nohist Plus, More... (4)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
